TNFRSF1A and inflammatory bowel disease: TNFR1 signalling via RIPK1 has been long recognised for its role in driving pathogenic pro-inflammatory cytokine and chemokine production in common diseases, such as Rheumatoid arthritis (RA), psoriasis, ankylosing spondylitis, and inflammatory bowel disease (IBD).